Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (51)
  • Endogenous Metabolite
    (41)
  • Antibacterial
    (35)
  • Autophagy
    (20)
  • NF-κB
    (20)
  • Antibiotic
    (16)
  • COX
    (15)
  • Antifungal
    (14)
  • Antifection
    (12)
  • Others
    (230)
Filter
Search Result
Results for "

20hydroxy prostaglandin e2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    554
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    3
    TargetMol | Compound_Libraries
  • Peptide Products
    28
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    6
    TargetMol | Dye_Reagents
  • PROTAC Products
    4
    TargetMol | PROTAC
  • Natural Products
    277
    TargetMol | Natural_Products
  • Recombinant Protein
    52
    TargetMol | Recombinant_Protein
  • Isotope Products
    20
    TargetMol | Isotope_Products
  • Antibody Products
    17
    TargetMol | Antibody_Products
  • Disease Modeling
    3
    TargetMol | Disease_Modeling_Products
  • Cell Research
    6
    TargetMol | Inhibitors_Agonists
20-hydroxy Prostaglandin E2
20-hydroxy Prostaglandin E2
T3783957930-95-7
20-hydroxy Prostaglandin E2 (20-hydroxy PGE2) is a product of cytochrome P450 metabolism of PGE2 . ω-Oxidation at C-20 followed by β-oxidation and the loss of up to four carbons from the lower side chain is a prominent metabolic pathway for PGE2. 20-hydroxy PGE2 is the putative first intermediate in this chain of chemical transformations.
  • $229
35 days
Size
QTY
Staurosporine
CGP 41251, Antibiotic AM-2282, AM-2282
T668062996-74-1
Staurosporine (AM-2282) is a protein kinase inhibitor with ATP-competitive and non-selective inhibitory activity (IC50=6/15/2/3/3000 nM) against PKC, PKA, c-Fgr, phosphorylase kinase and TAOK2. Staurosporine also induces apoptosis.
  • $56
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Dexamethasone
Prednisolone F, NSC 34521, MK 125, Hexadecadrol
T107650-02-2
Dexamethasone is a glucocorticoid receptor agonist and IL receptor modulator with anti-inflammatory, immunosuppressive, and apoptosis-inducing activities. It inhibits the production of inflammatory miRNA-155 exosomes in macrophages, significantly reduces inflammatory cytokine expression in neutrophils and monocytes, suppresses LPS-induced macrophage inflammation, and induces autophagy. It is commonly used to induce animal models of depression, muscle atrophy, and hypertension, and holds potential in COVID-19 research.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Axitinib
AG-013736
T1452319460-85-0
Axitinib (AG-013736) is a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1, VEGFR2, VEGFR3, and PDGFRβ (IC50=4/20/0.4/2 nM). Axitinib has antitumor activity and is used in the treatment of renal cell carcinoma.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
ATP
Triphosphoric acid adenosine ester, Triphosphaden, Atipi, Ara-ATP, Adenosine triphosphate
T2008956-65-5
ATP (Adenosine triphosphate) provides cellular energy, participates in overall energy balance, and maintains intracellular homeostasis. ATP can act as an extracellular signaling molecule through interactions with specific purinergic receptors to mediate a variety of processes including neurotransmission, inflammation, apoptosis, and bone remodeling.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Semaxinib
SU5416
T2064204005-46-9
Semaxinib (SU5416) is a potent and selective VEGFR2 inhibitor (IC50: 1.23 μM), exhibiting a 20-fold greater selectivity for VEGFR2 over PDGFRβ, with no activity against InsR, EGFR, and FGFR. Semaxinib reversibly inhibits ATP binding to the tyrosine kinase domain of VEGFR2, potentially inhibiting VEGF-stimulated endothelial cell migration and proliferation, thereby reducing tumor microvasculature.
  • $44
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Palmatine chloride
T271810605-02-4
Palmatine chloride an isoquinoline alkaloid, is an important medicinal herbal extract with diverse pharmacological and biological properties.
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Itacitinib
INCB39110, INCB039110
T39981334298-90-6
Itacitinib (INCB039110) is an orally bioavailable Janus-associated kinase 1 (JAK1) inhibitor with potential antineoplastic activity.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Tofacitinib
Tasocitinib, CP-690550
T6321477600-75-2
Tofacitinib (Tasocitinib) is a Janus kinase inhibitor that inhibits JAK3/2/1 (IC50=1/20/112 nM) and is orally active. Tofacitinib is used for the treatment of moderate to severe rheumatoid arthritis.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Valproic Acid
VPA, Sodium valproate, Depakine, 2-Propylvaleric Acid, 2-Propylpentanoic Acid
T706499-66-1
Valproic Acid (2-Propylpentanoic Acid) is an HDAC inhibitor that suppresses HDAC1 activity and induces HDAC2 degradation, exhibiting oral bioavailability. Valproic Acid activates Notch1 signalling and inhibits the proliferation of small cell lung carcinoma cells, making it applicable for research into epilepsy and bipolar disorder.
  • $50
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Darbufelone
CI-1004
T10960139226-28-1In house
Darbufelone (CI-1004) is a non-competitive dual inhibitor of PGF2α and LTB4. Dabfilon effectively inhibits PGHS-2 with a Ki of 10 μM and IC50s of 0.19 μM and 20 μM for PGHS-2 and PGHS-1.
  • $37
In Stock
Size
QTY
Darbufelone mesylate
CI-1004 mesylate
T10960L139340-56-0In house
Darbufelone mesylate (CI-1004 mesylate) inhibited PGF2α and LTB4 in cells and demonstrated IC50 values of 0.19 μM for PGHS-2 and 20 μM for PGHS-1.
  • $45
In Stock
Size
QTY
BPDBA
T26891312281-74-6In house
BPDBA is an effective, selective, and non-competitive inhibitor of the betaine/GABA transporter (BGT-1), displaying inhibitory activity against human BGT-1 and mouse GAT2, with IC50 values of 20 μM and 35 μM, respectively.
  • $37
In Stock
Size
QTY
SI-2
SI2, EPH 116, EPH116, EPH-116
T28773223788-33-8In house
SI-2 is an inhibitor (SMI) of steroid receptor coactivator-3 (SRC-3 or AIB1). SI-2 can selectively reduce the transcriptional activities and the protein concentrations of SRC-3 in cells, and selectively induce breast cancer cell death with IC50 values in the low nanomolar range (3-20 nM), but not affect normal cell viability.
  • $397
In Stock
Size
QTY
Geranylgeranyl pyrophosphate, t-BA (1:2)
Geranylgeranyl pyrophosphate tetrabutylammonium(1:2)(6699-20-3 Free base)
T40781L1 In house
Geranylgeranyl pyrophosphate tetrabutylammonium(1:2) is one of the endogenous cholesterol and intermediates produced by the mevalerate pathway. Geranylgeranyl pyrophosphate tetrabutylammonium(1:2) is the common precursor of diterpenoids, for example, Paclitaxel. It can be used for cancer research.
  • $195
In Stock
Size
QTY
ML299
VU0463568, ML-299
T89681426916-00-8In house
ML299 (VU0463568) is a dual PLD1/2 inhibitor (PLD1 and PLD2, IC50 of 6 nM, 20 nM, respectively).
  • $198
35 days
Size
QTY
1-Methoxycarbonyl-β-carboline
1-Methoxycarbonyl-beta-carboline
TN25493464-66-2In house
1-Methoxycarbonyl-β-carboline (1-Methoxycarbonyl-beta-carboline) is an alkaloid from Ailanthus altissima.
  • $189 TargetMol
In Stock
Size
QTY
(-)-Isopulegol
Fr1420789-79-2
Isopulegol has antioxidant, and neuroactive properties. It also has gastroprotective effects induced by isopulegol appear to be mediated, at least in part, by endogenous prostaglandins, K+ATP channel opening and antioxidant proprieties related to GSH incr
  • $29
In Stock
Size
QTY
Compound Fr14221
Fr142212814-20-2
Compound Fr14221, with CAS No. 2814-20-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14221 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
(2H),1,4-Benzothiazin-3(4H)-one
Fr212355325-20-2
(2H),1,4-Benzothiazin-3(4H)-one, with CAS No. 5325-20-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. (2H),1,4-Benzothiazin-3(4H)-one provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Compound PDK0215
PDK02154096-20-2
Compound PDK0215, with CAS No. 4096-20-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0215 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
18β-Glycyrrhetinic acid
Glycyrrhetin, Enoxolone
T0036471-53-4
18β-Glycyrrhetinic acid (Enoxolone) is the major bioactive component of Glycyrrhizae Radix and possesses anti-ulcerative, anti-inflammatory and antiproliferative properties.
  • $29
In Stock
Size
QTY
TargetMol | Citations Cited
Diammonium Glycyrrhizinate
Diammonium Glycyrrhizin
T052279165-06-3
Diammonium Glycyrrhizinate (Glycyrrhizin) , an extensively used anti-inflammatory agent, is isolated from the licorice root. It is metabolized to glycyrrhetinic acid, which inhibits 11-β-hydroxysteroid dehydrogenase and other enzymes involved in the metabolism of corticosteroids. Therefore, glycyrrhizic acid, the main and sweet component of licorice, has been studied for its ability to cause hypermineralocorticoidism with potassium loss and sodium retention, edema, increased blood pressure, as well as inhibited the renin-angiotensin-aldosterone system.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Myricetin
Cannabiscetin
T0579529-44-2
Myricetin (Cannabiscetin) is a natural flavonoid and MEK1 inhibitor. Myricetin has hypoglycemic, antioxidant, hepatoprotective, anti-tumor and anti-inflammatory activities.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited